Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.
Iyengar P, All S, Berry MF, Boike TP, Bradfield L, Dingemans AC, Feldman J, Gomez DR, Hesketh PJ, Jabbour SK, Jeter M, Josipovic M, Lievens Y, McDonald F, Perez BA, Ricardi U, Ruffini E, De Ruysscher D, Saeed H, Schneider BJ, Senan S, Widder J, Guckenberger M. Iyengar P, et al. Among authors: de ruysscher d. Pract Radiat Oncol. 2023 Sep-Oct;13(5):393-412. doi: 10.1016/j.prro.2023.04.004. Epub 2023 Apr 25. Pract Radiat Oncol. 2023. PMID: 37294262
Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A, Nijsten S, Hochstenbag M, Lamers R, Boersma L, Wanders R, Lutgens L, Zimny M, Bentzen SM, Wouters B, Lambin P, De Ruysscher D. van Der Wel A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):649-55. doi: 10.1016/j.ijrobp.2004.06.205. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708242
HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.
De Ruysscher D, Wanders R, van Haren E, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Verschueren T, Minken A, Bentzen SM, Lambin P. De Ruysscher D, et al. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):132-8. doi: 10.1016/j.ijrobp.2007.09.048. Epub 2007 Nov 26. Int J Radiat Oncol Biol Phys. 2008. PMID: 18037581 Clinical Trial.
Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
van Baardwijk A, Bosmans G, Bentzen SM, Boersma L, Dekker A, Wanders R, Wouters BG, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1103-10. doi: 10.1016/j.ijrobp.2007.11.028. Epub 2008 Feb 6. Int J Radiat Oncol Biol Phys. 2008. PMID: 18258382 Clinical Trial.
Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
Dehing-Oberije C, Yu S, De Ruysscher D, Meersschout S, Van Beek K, Lievens Y, Van Meerbeeck J, De Neve W, Rao B, van der Weide H, Lambin P. Dehing-Oberije C, et al. Among authors: de neve w, de ruysscher d. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):355-62. doi: 10.1016/j.ijrobp.2008.08.052. Epub 2008 Dec 25. Int J Radiat Oncol Biol Phys. 2009. PMID: 19095367
Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.
Spoelstra FO, Senan S, Le Péchoux C, Ishikura S, Casas F, Ball D, Price A, De Ruysscher D, van Sörnsen de Koste JR; Lung Adjuvant Radiotherapy Trial Investigators Group. Spoelstra FO, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1106-13. doi: 10.1016/j.ijrobp.2009.02.072. Epub 2009 Jun 27. Int J Radiat Oncol Biol Phys. 2010. PMID: 19560881
489 results